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Abstract
Background: Self-care practices for patients with hypertension include adherence to medication,
use of blood pressure self-monitoring and use of complementary and alternative therapies (CAM)
The prevalence of CAM use and blood pressure self-monitoring have not been described in a UK
secondary care population of patients with hypertension and their impact on adherence to
medication has not been described. Adherence to medication is important for blood pressure
control, but poor adherence is common. The study aimed to determine the prevalence of self-care
behaviours in patients attending a secondary care hypertension clinic.
Methods:  Cross-sectional questionnaire survey. 196 patients attending a secondary care
hypertension clinic in a teaching hospital serving a multiethnic population, Birmingham, UK. Main
outcome measures: Prevalence of use of CAM, home monitors, adherence to anti-hypertensive
medication.
Results: CAM use in previous 12 months was reported by 66 (43.1%) respondents. CAM users
did not differ statistically from non-CAM users by age, gender, marital status or education.
Vitamins, prayer a dietary supplements were the most commonly used CAM. Nine (12.7%) women
reported using herbal CAM compared to one man (1.2%), (p = 0.006). Ten (6.7%) respondents
reported ever being asked by a doctor about CAM use. Perfect adherence to anti-hypertensive
medication was reported by 26 (44.8%) CAM-users and 46 (60.5%) non-CAM users (p = 0.07).
Being female and a CAM user was significantly associated with imperfect adherence to anti-
hypertensive medication. Older and white British respondents were significantly more likely to
report perfect adherence. Blood pressure monitors were used by 67 (43.8%) respondents, which
was not associated with gender, CAM use or adherence to medication.
Conclusion: Hypertensive patients use a variety of self-care methods, including CAM, home blood
pressure monitors, and adherence to prescribed medication. This study found the prevalence of
CAM use in hypertensive patients was higher than in the UK population. It is important to
acknowledge the self-care behaviour of hypertensive patients, in order to assess potential harm,
and encourage effective methods of self-care.
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Background
Self-care describes the maintenance of health, prevention
and treatment of illness by an individual [1,2]. It has been
shown to improve patient satisfaction, quality of life, and
also reduce primary care, outpatient and emergency
department visits [3]. The four components of self-care are
leading a healthy lifestyle, treating minor ailments, man-
aging chronic conditions and care after hospital discharge
[1]. The National Health Service in the UK is committed
to supporting and making provision for self-care in the
management of chronic conditions [2], which can include
empowering patients to self-manage their condition using
home blood pressure monitors, as well as encouraging
adherence to medication [3]. Hypertension (high blood
pressure) is a highly prevalent chronic condition, affecting
32% of men and 30% of women aged 16 or over in Eng-
land [4]. It is a modifiable but important risk factor for
coronary heart disease and stroke [5]. Self-care for hyper-
tension includes lifestyle measures such as maintaining a
healthy weight and diet, as well as adhering to medica-
tion, to help patients achieve blood pressure (BP) control
[3,5,6].
One form of self-care, complementary and alternative
medicine (CAM) is becoming increasingly popular, with
overall CAM sales in the UK rising by 23% since 1998 [7].
Although the one-year prevalence of CAM use in the gen-
eral UK population is 20% [7], a higher prevalence of
CAM use has been associated with a diagnosis of chronic
disease [8-10]. There have been no reports of CAM use in
hypertensive patients attending secondary care clinics in
the UK, but CAM use in hypertensives has been reported
for the USA [10,11] and in Singapore [12] and other stud-
ies have focussed on cardiovascular disease [13-15]. In
addition, the evidence base for using CAM to manage
hypertension has not been demonstrated definitively, as
studies assessing the influence of CAM on BP reduction
have been small scale, or uncontrolled [16], although
CAM relaxation therapies have been reported to produce
small BP improvements [17].
Supplements or natural products, containing for example
herbs, can cause unpredicted effects, drug interactions,
and even compromise BP control [5,18,19]. However it is
known that patients do not limit their CAM use to condi-
tions where its use is evidence-based [9], or proven to be
safe [15]. There is also evidence that CAM users fail to
report their use of CAM [7,18] and are more likely than
non-CAM users to believe CAM is safe [20,21]. It is there-
fore imperative to have specific information on the preva-
lence of CAM use in the hypertensive clinic.
Poor adherence to prescribed medication is associated
with treatment failure and poor BP control [22,23], with
only 50–70% of hypertensive patients adherent, and the
prevalence of adherence varying by the study population,
length of diagnosis and method of assessment [22]. Up to
50% of CAM users in the general population report using
CAM alongside prescribed medication [18], as CAM tends
to be used as a complement rather than as a replacement
for conventional medicine [9,21], this should not
adversely affect adherence to prescribed anti-hypertensive
medication. However, CAM use is decided by many fac-
tors, which may be the positive qualities of CAM, or neg-
ative aspects of conventional care [24]. Although
adherence has been extensively researched, it is not fully
understood [22], and as CAM prevalence increases, its
influence on adherence requires consideration. Current
research into the influence of CAM on adherence is lim-
ited and has not focussed on hypertensive patients.
Like the use of CAM and adherence to prescribed medica-
tion, the use of home blood pressure monitors is another
aspect of self-care relevant to the management of hyper-
tension. The use of home monitoring BP devices can aid
diagnosis, has been shown to be effective in improving BP
control, although the mechanism for this is unknown
[25], and also reduces the 'white coat effect' [23,26,27].
The influence of home BP monitors on adherence to anti-
hypertensive medication is less well known [28]. Like
CAM, there has been recent interest from the public in
purchasing home monitors from pharmacies and over the
internet [23], and the only published survey of use of BP
self-monitoring reported a 9% prevalence in a postal sur-
vey of a UK adult primary care population [29]. Logistic
regression showed predictors of use were increasing age,
female gender, having a university degree and living in a
more affluent area
Home BP monitors have a role in encouraging personal
control of hypertension and other cardiovascular disease
risk factors [26] and can positively reinforce self-care
behaviour such as adherence to medication in the man-
agement of chronic disease [30].
The objectives of the study reported here were to describe
(i) the prevalence of and factors associated with CAM use
in hypertensive patients attending secondary hyperten-
sion clinics, (ii) adherence to anti-hypertensive medica-
tion and its relationship to CAM use, and (iii) the use of
home blood pressure monitors by hypertensive patients,
as part of self-care.
Methods
This cross-sectional descriptive survey was undertaken at
outpatient hypertension clinics at a teaching hospital in
Birmingham, UK. This hospital serves a multiethnic com-
munity of 350,000, with an ethnic prevalence of approxi-
mately 25% south Asian, 11% Afro-Caribbean and 64%
white European [31]. Between February and April 2006,BMC Complementary and Alternative Medicine 2008, 8:4 http://www.biomedcentral.com/1472-6882/8/4
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196 consecutive English speaking or non-English speak-
ing patients with family members able to translate, were
approached and asked to complete a questionnaire by the
researcher. Written consent was obtained. The question-
naire was verbally administered to consenting respond-
ents who were unable to self-complete the survey. Ethical
approval was granted by the local Research Ethics Com-
mittee.
Survey design
Data were collected on demographic characteristics, CAM
use, adherence to prescribed medication and use of home
blood pressure monitors. CAM use over the previous 12
months was identified using a tick list based on the five
categories of CAM classified by the National Centre for
Complementary and Alternative Medicine [32]. One-year
prevalence, rather than lifetime use, was used to reduce
recall bias [33]. The following open question asked
responders to specify which dietary supplements or vita-
mins were used: 'if you have ticked dietary supplements or
vitamins, please list the names of all those which you have
used (e.g. vitamin C, garlic capsules, cod liver oil, Sana-
togen etc). The use of CAM specific for the management
of hypertension was not determined. Instead, responders
were asked about any CAM use over the past year, as it was
felt any CAM use, whether or not specifically used for
hypertension, could interact with medication [7]. In addi-
tion, any CAM use could influence adherence to anti-
hypertensive medication, as it has been shown that CAM
users are often dissatisfied with conventional care [7].
Respondents were also asked if they had ever been asked
by a doctor about CAM use.
Adherence to prescribed medication was tested using an
adapted version of the Hill-Bone compliance to high
blood pressure therapy scale [34,35]. Using 8 questions,
this assessed adherence by assessing patients' forgetful-
ness in taking medication, filling prescriptions and ensur-
ing they did not run out of medication and asked about
circumstances in which patients might not take their BP
medication. Minor wording changes were made to modify
the American scale for use in the UK setting [see addi-
tional file 1]. Responses ranged from none of the time
(scoring 1) to some, most, or all of the time (scoring 4),
so adherence scores of 8 and greater than 8 indicated per-
fect and imperfect adherence respectively.
Statistical analysis
SPSS version 13.0 was used for data analysis. Chi-squared
and Fishers Exact test, as appropriate, were used to analyse
categorical variables, comparing gender, ethnicity and
marital status with CAM use, home blood pressure moni-
toring equipment use and adherence to medication (per-
fect or imperfect). CAM users were defined as those who
had used at least one CAM in the previous 12 months.
Logistic regression was used for the univariate analysis of
perfect adherence, CAM use and use of home BP monitor-
ing tests with the continuous variables age, education and
time since their diagnosis of hypertension. Tests were 2-
tailed, and a p-value ≤ 0.05 was considered statistically
significant. A multivariate analysis of the predictors of per-
fect adherence to prescribed medication was undertaken.
Results
Characteristics of sample
Of 196 questionnaires distributed, 153 (78.8%) were
completed. The sample included similar numbers of male
and female respondents, with 82 (53.6%) being male and
mean age 57.3 (SD = 16.0) years (Table 1).
Assessment of CAM use
CAM use was organised and analysed according to the five
categories identified by the National Centre for Comple-
mentary and Alternative Medicine: alternative medical;
mind-body; manipulation/body-based; energy, and bio-
logical based therapies. CAM users did not differ signifi-
cantly from non-CAM users by age, gender, marital status,
education, ethnicity or comorbidity. Sixty-seven (43.7%)
respondents had used at least one CAM in the past 12
months. Excluding prayer, the CAM prevalence was
37.9% (n = 58). Vitamin supplements, prayer, dietary sup-
plements and relaxation were the most frequently used
(Table 2). Cod liver oil, multi-vitamins and garlic were the
most popular vitamin and dietary supplements. Nine
(12.7%) of women reported using herbal CAM compared
to one man (1.2%), (p = 0.006). Although more women
used CAM than men (33, 49.3% v 33, 40.2%), this was
not significant. Only 10 (6.7%) respondents reported ever
being asked by a doctor about their use of CAM.
Assessment of adherence to anti-hypertensive medication
134 (87.6%) respondents reported they were prescribed
anti-hypertensive medication. Twenty six (44.8%) users
compared to 46 (60.5%) non-users of CAM who reported
being prescribed antihypertensive medication reported
perfect adherence (Table 3). No significant differences
were observed between patients who reported perfect or
sub-optimal medication adherence for gender, any CAM
use, CAM use excluding vitamin and dietary supplement
use, ethnicity, duration since hypertension diagnosis, or
education. However, a significant difference between
female CAM and non-CAM users and adherence was
found, with eleven (35.9%) females using CAM reporting
perfect adherence, compared to 23 (63.9%) women who
had not used any CAM in the previous twelve months (p
= 0.02). The same analysis was not significant for males.
Pearson's chi-squared showed white British respondents
were significantly more likely to be perfectly adherent
compared to all other ethnicities (67.1% v 32.9%, p <BMC Complementary and Alternative Medicine 2008, 8:4 http://www.biomedcentral.com/1472-6882/8/4
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0.001). The mean age of adherent patients was 60.2 years
(range 23 to 86 years) compared to 53.7 years (range 23
to 88 years) for non-adherent patients (p = 0.02). In a
logistic regression model including age, gender, ethnicity,
CAM use, duration of hypertension and years of educa-
tion, increasing age predicted perfect adherence (OR 1.03,
95% CI 1.00, 1.06) and being of ethnic minority ethnicity
predicted lower adherence (OR 0.31, (95% CI 0.14, 0.72).
Assessment of use of home blood pressure monitors
Home BP monitors were used by 66 (43.1%) of respond-
ents (Table 4). The main source of monitors was pharma-
cies and chemists for 30 (45.5%) respondents, and 15
(22.7%) obtained them from family or friends. Twenty-
seven (40.9%) BP monitor users reported using the mon-
itor for monitoring purposes, while 8 (12.1%) had used a
monitor after a high reading, in order to diagnose hyper-
tension. The use of BP monitors was not significantly
associated with gender, any CAM use, CAM use excluding
vitamin and dietary supplement use, or adherence to anti-
hypertensive medication.
Discussion
Prevalence of CAM use
A higher prevalence of CAM use in this secondary care
hypertensive population was found compared to the
reported UK general population, reflecting findings of
studies of other chronic disease patients [8,36,37]. Eisen-
berg et al. showed that despite a high prevalence of use of
CAM by hypertensive patients also using conventional
care, none believed that CAM was better than conven-
tional care for their condition [38].
A CAM prevalence (excluding non-prescribed vitamin or
dietary supplement use) of 14.5% in diagnosed hyperten-
sives was described by a primary care study in Singapore
Table 1: Characteristics of respondents: users and non-users of CAM
Total (100%) n = 153 CAM users (43.8%) n = 67 Non-CAM users (56.2%) n = 86
Mean age, years (SD) 57.3 (16.0) 55.9 (15.7) 58.4 (16.3)
Age < 60 years 79 (51.6) 39 (58.2) 40 (46.5)
Gender
males 82 (53.6) 34 (50.7) 48 (57.0)
females 71 (46.4) 33 (49.3) 38 (44.2)
Marital Status
Single 31 (20.3) 14 (20.8) 17 (19.8)
Married/co-habiting 89 (58.2) 34 (50.7) 55 (64.0)
Divorced/separated 15 (9.8) 11 (16.4) 4 (4.7)
Widowed 17 (11.1) 7 (10.4) 10 (11.6)
Mean years in Education (SD) 12.25 (4.5) 12.20 (4.0) 12.28 (4.9)
Ethnicity (%)
White British 90 (59.2) 33 (49.3) 57 (66.3)
White Irish 7 (4.6) 6 (9.0) 1 (1.7)
Asian/Asian British Indian 18 (11.8) 10 (14.9) 8 (9.3)
Asian/Asian British Pakistani 9 (5.9) 3 (4.5) 6 (7.0)
Black/Black British Caribbean 19 (12.5) 12 (17.9) 7 (8.1)
Other1 9 (6.1) 2 (3.0) 7 (8.1)
Co morbidity
Poor circulation in legs 41 (26.8) 21 (31.3) 20 (23.3)
Diabetes 24 (15.7) 11 (16.4) 13 (15.1)
Stroke 16 (10.5) 8 (11.9) 8 (9.3)
Angina 20 (13.1) 11 (16.4) 9 (10.5)
Heart valve problems 12 (7.8) 10 (14.9) 2 (2.3)
Heart attack 8 (5.2) 4 (8.0) 4 (4.7)
Atrial fibrillation 7 (4.6) 2 (3.0) 5 (5.8)
Renal complications 7 (4.6) 6 (9.0) 1 (1.2)
Asthma 6 (3.9) 2 (3.0) 4 (4.7)
Arthritis/musculoskeletal 13 (8.5) 8 (11.9) 5 (5.8)
Hypertension
Mean duration of hypertension 
diagnosis, years
10.1 (SD = 10.2) 9.2 (SD = 7.8) 10.9 (SD = 11.9)
Hypertensives diagnosed within 
last year (%)
17 (11.1) 7 (10.4) 10 (11.6)
1Other ethnicity: White other (n = 3); Asian/Asian British Bangladeshi (n = 1); Asian/Asian British other (n = 1); Black/Black British African (n = 3); 
Mixed (n = 1).BMC Complementary and Alternative Medicine 2008, 8:4 http://www.biomedcentral.com/1472-6882/8/4
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[12], which is lower than the comparative figure in our
study (26.1%). Surveys of CAM use in cardiovascular dis-
ease in the US have found a greater prevalence of use than
is seen in the general population, which is itself higher
than in the UK [8,10,11]. A survey of pre-cardiac surgery
patients which included exercise as a CAM modality [10]
found a CAM prevalence of 80.9% and a large population
survey in the USA reported a lower prevalence of 69.5% of
hypertensives aged 65 years or more [11]. A survey in an
American cardiovascular outpatient clinic of biological-
based CAM therapies found a one-year prevalence of 42%
[15], compared to 28.8% found in this study. These stud-
ies are not directly comparable with this research due to
differences in range of cardiovascular diagnoses included,
the study setting and the CAM categories included.
Population studies have shown CAM use to be signifi-
cantly associated with being white, middle aged, well edu-
cated and female [11,21,37,39]. However, no significant
differences between CAM and non-CAM users for ethnic-
ity, age, education or gender were reported in our sample
of hypertensive patients. Within CAM use, there were also
no significant differences by gender, other than for herb-
alism, which was significantly more likely to be used by
females. These findings suggest CAM users in the hyper-
tension clinic do not fit the demographic patterns seen in
population studies. However, the definitions of CAM use
vary between surveys which may also explain the differ-
ences found. In addition, our survey was carried out at one
UK teaching hospital, and therefore are not generalisable
to all hypertensive patients attending secondary care out-
Table 2: Use of CAM, vitamin & dietary supplements, by gender
Males (%) n = 82 Females (%) n = 71 Total (%) n = 153
Used CAM1 33 (40.2) 33 (49.3) 66 (43.1)
Excluding Prayer 28 (34.1) 30 (42.3) 58 (37.9)
Alternative medical system
Chinese medicine 2 (2.4) 2 (2.8) 4 (2.6)
Homeopathy 0 3 (4.2) 3 (2.0)
Mind-body intervention
Prayer 11 (13.4) 8 (11.3) 19 (12.4)
Relaxation 6 (7.3) 7 (9.9) 13 (8.5)
Aromatherapy 3 (3.7) 4 (5.6) 7 (4.6)
Meditation 1 (1.2) 3 (4.2) 4 (2.6)
Spiritual healing 0 3 (4.2) 3 (2.0)
Yoga 0 2 (2.8) 2 (1.3)
Tai chi 0 1 (1.4) 1 (0.7)
Manipulative/body-based
Massage therapy 4 (4.9) 3 (4.2) 7 (4.6)
Acupuncture 3 (3.7) 2 (2.8) 5 (3.3)
Reflexology 1 (1.2) 3 (4.2) 4 (2.6)
Energy therapies
Energy healing 0 2 (2.8) 2 (1.3)
Magnetic therapy 1 (1.2) 0 1 (0.7)
Biological Based
Vitamin supplements 14 (17.1) 17 (23.9) 31 (20.3)
Dietary supplements 11 (13.4) 6 (8.5) 17 (11.1)
Herbal medicine3 1 (1.2)* 9 (12.7)* 10 (6.5)
Any biological therapy 19 (23.2) 25 (35.2) 44 (28.8)
Vitamin/Dietary Supplements2
Cod liver oil 11 (13.4) 10 (14.1) 21 (13.7)
Multivitamins 4 (4.9) 7 (9.9) 11 (7.1)
Garlic 3 (3.7) 5 (7.0) 8 (5.2)
Vitamin C 3 (3.7) 4 (5.6) 7 (4.6)
Glucosamine 3 (3.7) 3 (4.2) 6 (3.9)
Vitamin B/B12 2 (2.4) 1 (1.4) 3 (2.0)
Omega-3 1 (1.2) 1 (1.4) 2 (1.3)
Nutritional drinks 0 2 (2.8) 2 (1.3)
Primrose Oil 0 2 (2.8) 2 (1.3)
1CAM Modalities not used: Ayurveda, Naturopathy, Qi Gong (Alternative system), Biofeedback, Guided Imagery, Hypnosis (Mind-body 
interventions), Chelation (Biological), and chiropractic (Manipulative technique).
2Vitamin/diet supplements used by n = 1 (0.7%): Vitamin D, Folic Acid, Cranberry Juice, Selenium, Spirulina, Chondroitin, Silica.
3Significant p = 0.006.
4Vitamin & dietary supplements were analysed togetherBMC Complementary and Alternative Medicine 2008, 8:4 http://www.biomedcentral.com/1472-6882/8/4
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patient clinics. Clinic non-attendees were obviously
excluded, and 21% of patients approached did not com-
plete a questionnaire, introducing some response bias.
CAM use in ethnic minorities has been little established,
although patterns of CAM use have been shown to differ
by ethnicity [39,40]. In our study, white British and Asian
British Pakistani respondents were least likely to report
CAM use. The use of CAM by black and Asian adults was
also indicated to be considerable in a US population study
[8]. There is therefore a complex association between eth-
nicity and CAM use which requires further investigation,
as, although this sample was ethnically diverse, the num-
bers in individual ethnic groups were too small to allow
significant conclusions to be made. One limitation of our
study was the inclusion of questionnaires translated by
family members, rather than the ideal of either a trans-
lated questionnaire or use of an interpreter. Although less
than 5% of the sample, these were included in order to
avoid exclusion bias. It was also felt that this mirrored the
Table 3: Adherence to anti-hypertensive medication
Perfect Adherence (%) Non-perfect Adherence (%) Total (%) p value
Gender
Males 38 (56.7) 29 (43.3) 67 0.49
Females 34 (50.7) 33 (49.3) 67
Cam users
Cam use 26 (45.6) 31 (54.4) 57
No CAM use 46 (59.7) 31 (40.3) 77 0.11
Gender and CAM use
Male & CAM 15 (57.7) 11 (42.3) 26
Male & no CAM 23 (56.1) 18 (43.9) 41 0.90
Female & CAM 11 (35.5) 20 (64.5) 31
Female & no CAM 23 (63.9) 13 (36.1) 36 0.02
Ethnicity
White British 55 (67.1) 27 (32.9) 82 <0.001
All other 17 (32.7) 35 (67.3) 52
Age (SD) 60.17 (14.7) 53.72 (16.2) 56.95 (15.5) 0.02
BP monitor
Users 29 (49.2) 30 (50.8) 59 0.55
Non-users 33 (44.0) 42 (56.0) 75
Duration of hypertension 
diagnosis, yr (SD)
9.96 (10.54) 11.30 (10.9) 10.63 (10.72) 0.48
Education, yr (SD) 12.44 (4.70) 12.32 (4.14) 12.38 (4.42) 0.88
Table 4: Use of home monitoring tests for all respondents, and by CAM use and gender
Total (%) n = 153 CAM users (%) n = 67 No CAM (%) n = 86
BP home monitor 66 (43.8) 33 (50.7) 33 (38.4)
Reason for home BP monitor
hypertension diagnosis 8 (14.3) 5 (15.2) 3 (9.1)
advised by doctor 7 (12.5) 3 (9.1) 4 (12.1)
to aid diagnosis 4 (7.1) 3 (9.1) 1 (3.0)
felt unwell/concerned 4 (7.1) 1 (3.0) 3 (9.1)
for monitoring 27 (48.2) 15 (45.5) 12 (36.4)
already had access 2 (3.6) 1 (3.0) 1 (3.0)
curiosity 1 (1.8) 0 1 (3.0)
can't remember 1 (1.8) 0 1(3.0)
Source of monitor
Pharmacy/chemist 30 (45.5) 16 (48.5) 14 (42.4)
Postal ordered 6 (9.1) 3 (9.1) 3 (9.1)
Internet 1 (1.5) 0 1 (3.0)
Family/friend 15 (22.7) 8 (24.2) 7 (21.2)
Doctor 5 (7.6) 3 (9.1) 2 (6.1)
Other 9 (13.6) 3 (9.1) 6 (18.2)
BP: blood pressureBMC Complementary and Alternative Medicine 2008, 8:4 http://www.biomedcentral.com/1472-6882/8/4
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situation in the consultation itself, and that the question-
naire did not cover particularly sensitive issues which
would require an independent interpreter. We acknowl-
edge that the relatively small size of our sample is a limi-
tation of our study.
The biological therapies, vitamin, dietary and herbal sup-
plements, were the most used CAM group, and within
these, cod liver oil and garlic were among the three most
used supplements. Cod liver oil contains omega-3 fatty
acids, the benefits of which are still unproven for cardio-
vascular disease [14]. The high doses required for BP
reduction have significant side effects and as a result
omega-3 is not routinely recommended as a treatment for
hypertension [6]. The benefits of garlic supplementation
also remain unproven, with many small trials reporting
only short-term BP improvements [7,18].
Vitamins and dietary supplements were included in this
survey as biological-based CAM therapies as they are
widely accessible, available over the counter, and have
been shown to have a high prevalence of use in popula-
tion surveys [8,18,41]. Prayer was also included in this
study as a result of its inclusion in large CAM prevalence
surveys [8,11,21]. The definition of CAM is wide [32,42]
which explains why surveys vary in the number and cate-
gorization of CAM therapies included [42]. To explore the
possibility that our findings may have been strongly influ-
enced by the inclusion of vitamins and dietary supple-
ments, we re-ran the analyses using a narrower definition
of CAMs (excluding vitamins and dietary supplements).
Our findings did not change in relation to adherence to
antihypertensive medication and use of home BP moni-
tors.
After vitamins, dietary supplements and prayer use, the
most frequently used CAM therapies were relaxation,
herbal medicine, aromatherapy and massage therapy.
These are amongst the most commonly used in the UK
population, along with acupuncture, reflexology, and
homeopathy [36]. Studies are ongoing into the benefits of
CAM for hypertension, but relaxation therapies are not
recommended currently as part of routine NHS treatment
for hypertension [5].
Reporting CAM use to a medical practitioner
Only 6.7% of the sample reported being asked about their
CAM use by a doctor which compares to a previously
reported figure of 3.4% [8]. Knowledgeable doctors
trained in CAM are more likely to ask about CAM use
[43,44]. However, a study in Israel reported that doctors
estimated that 15% of their patients used a CAM, suggest-
ing that they underestimate their patients' CAM use [43],
and found that many were unaware of the potential harms
of these therapies [43,44]. Patients are also reluctant to
voluntarily disclose their use of CAM, with 57% to 70%
failing to tell their doctor about CAM use [18,20,21,38]
with fear of disinterest by the treating physician being the
most commonly cited reason for this [45]. Only a minor-
ity of patients use CAM prior to accessing conventional
services so this could be addressed by broaching the issue
of CAM use sensitively, avoiding making assumptions,
while respecting patients' self-care choices and providing
guidance regarding CAM and self-care [42,45].
CAM use and adherence to antihypertensive medication
This study shows CAM use was significantly associated
with reduced adherence to anti-hypertensive medication
for females. The reason for this, and why females may dif-
fer from males in adherence to medication while using
CAM requires further work. Studies evaluating the influ-
ence of CAM use on adherence are limited with conflict-
ing results. Jernewall et al's study of HIV positive Latino
men, found that use of plant-based CAM was significantly
associated with non-adherence to conventional medica-
tion [46]. In contrast, a study of lung transplant patients
found 88% were using some form of CAM, and CAM users
did not differ from non-CAM users in the percentage
reporting adherence to the transplant regime [47]. Further
work is therefore required into the relationship between
CAM use and adherence to prescribed medication before
conclusions can be made.
In this study, seventy two (41.7%) respondents reported
perfect adherence, which is lower than the 50 to 70%
reported in previous studies of patients diagnosed with
hypertension for more than one year [48]. This may be
due to differences in the method of measuring adherence.
This study also found older age and white British ethnicity
to be positively related to perfect adherence, in line with
previous research [48]. The gold standard for measuring
adherence, electronic measurement, was an unsuitable
method for this survey [23]. To reduce non-response and
social acceptability bias, a confidentiality reminder clause
was inserted immediately above the adherence question
in the questionnaire and on the patient information sheet
before consent was obtained.
While over 40% of the sample had used a home BP mon-
itor, only a minority cited doctors' advice as the reason for
its use. Pharmacies and chemists were the main source for
monitors in this study, and retail sales are expected to
increase further as self-care becomes more popular [23].
Home monitoring in a randomised control trial was
shown to lead to less intensive medication regimes, but
also resulted in reduced BP control [27]. Self-monitoring
BP has also been shown to assist weight loss, reduce BP, to
be cost effective and does not increase patient anxiety
[26]. However, patients require training in using moni-
tors, and understanding and interpreting readings appro-BMC Complementary and Alternative Medicine 2008, 8:4 http://www.biomedcentral.com/1472-6882/8/4
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priately to maximise the benefits of self-monitoring [23].
This was reflected by a systematic review which found that
in six of the eleven randomised control trials included,
adherence was significantly improved with home BP
monitoring [28]. When home BP monitoring was used
with other interventions, including patient counselling
and education, the effect on adherence was greater [28].
The potential benefits should be recognised and further
researched [26,27,49], and doctors need to be aware of
the high level of patient use and routinely ask about this
in the consultation.
Conclusion
This study has shown hypertensive patients use self-care
in a variety of forms, which include CAM and home mon-
itors, as well as adhering to prescribed medication. The
prevalence of CAM use in this study is higher than in the
UK population. However not all the CAM methods used
by the respondents have been proven to have beneficial
effects by conclusive evidence-based research, and may
even be potentially harmful. It is therefore important to
monitor and encourage effective methods of self-care in
association with proven conventional care.
A significant association between CAM use and less than
perfect adherence was found for females in this study.
CAM use may therefore have some influence on adher-
ence, however this requires further investigation, as
research is limited in this area.
Home blood pressure monitors were used by a significant
proportion of this hypertensive sample in order to self-
manage their condition, and only a minority of these
patients had been recommended to use a BP monitor by a
health care professional. Home BP monitoring is popular
with patients, but patient education and training is
required to achieve maximum benefits from the use of
home monitors, and the role of monitors in the manage-
ment of hypertension therefore requires further research.
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